SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges

SARS-CoV-2 is responsible for the 2020 global coronavirus disease 2019 (COVID-19) pandemic. In patients with COVID-19, multiple cardiovascular (CV) manifestations have been reported. SARS coronavirus 2 infection can lead to inflammatory CV disease first via takeover of the angiotensin-converting enz...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Future Cardiol
Auteurs principaux: Shah, Kevin S, Hale Hammond, Mary Elizabeth, Drakos, Stavros G, Anderson, Jeffrey L, Fang, James C, Knowlton, Kirk U, Shaw, Robin M
Format: Artigo
Langue:Inglês
Publié: Future Medicine Ltd 2021
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7986052/
https://ncbi.nlm.nih.gov/pubmed/33739142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fca-2020-0188
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires